Short Interest in iShares Health Innovation Active ETF (NYSEARCA:BMED) Rises By 159.2%

iShares Health Innovation Active ETF (NYSEARCA:BMED) saw a large growth in short interest in the month of June. As of June 15th, there was short interest totaling 1,472 shares, a growth of 159.2% from the May 31st total of 568 shares. Based on an average daily trading volume, of 1,249 shares, the short-interest ratio is presently 1.2 days. Currently, 0.4% of the company’s shares are short sold.

iShares Health Innovation Active ETF Stock Down 0.5%

BMED traded down $0.15 during trading on Tuesday, reaching $30.62. The company had a trading volume of 1,195 shares, compared to its average volume of 3,817. The business has a 50 day simple moving average of $28.41 and a 200-day simple moving average of $29.56. The stock has a market cap of $11.02 million, a P/E ratio of 24.91 and a beta of 0.75. iShares Health Innovation Active ETF has a 52 week low of $24.50 and a 52 week high of $32.19.

Institutional Investors Weigh In On iShares Health Innovation Active ETF

A hedge fund recently bought a new stake in iShares Health Innovation Active ETF stock. Sunbelt Securities Inc. acquired a new position in iShares Health Innovation Active ETF (NYSEARCA:BMED) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 11,612 shares of the company’s stock, valued at approximately $352,000. Sunbelt Securities Inc. owned 3.63% of iShares Health Innovation Active ETF at the end of the most recent reporting period.

About iShares Health Innovation Active ETF

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.